Social Media for Clinical Research Data?
Keeping abreast of the rapid developments with social media is not easy, particularly in the highly regulated biopharmaceutical environment. Every week, something new happens that prompts debate and outpourings from various sources. So you can imagine my surprise when considering that social networks were really for marketing purposes, I came across a blog in the [...]
Reflections from DIA 2: Real time data
Just a quick observation on a trend that I have noticed over the last year or so that I find interesting is the emergence of research organisations and the regulators in using their data more imaginatively. Fergus Sweeney from the EMA, in a panel discussion at the DIA Euro Meeting in 2010, said that research [...]
4 Comments